Skip to content
Clinical Trial Services - Criterium - Global CROLearn More

Learn how IRT and remote monitoring keep trials running smoothly

Coronavirus and Clinical Trials:
Criterium Technology ensures that research never stops

Criterium - Clinical Trials - CRO

Get To Know Us!

We are the Premier Hands-on CRO

Therapeutic Areas - Clinical Trial CRO - Criterium

Get To Know Us!

We are the Premier Hands-on CRO

Criterium Global CRO - Clinical Trial Services, Clinical Research

Get To Know Us!

We are the Premier Hands-on CRO

Criterium

Thank you to all of our partners, colleagues and sponsors
who continue to make Criterium a success!

Celebrating 30 Years of Clinical Trial Innovation & Excellence

Innovative Clinical Research Solutions

- Since 1991 -

Full-Service, Dedicated, Data Driven – from “Thought to Finish”, Every Trial, Every Time.

Consider it Done!

High level of expertise & high-value technology for every trial

Our Unique Centralized Network Model (CNM) for Translational Research

Clinical Development tailored to each client’s needs

Seamless interfacing with ancillary support technologies

Our expertise covers a wide range of clinical indications:

What’s New in Breast Cancer Research and Treatment?
Criterium's Academic Breast Cancer Consortium (ABRCC) is comprised of 15 renowned academic and community sites in North America, conducting translational research in Breast Cancer studies for major pharmaceutical companies who are working on the most current clinical trials for advanced treatments of breast cancer. While 2020 was a year dominated by COVID-19 news and tragedy, breast cancer research and breakthroughs can't wait for COVID to "go away" – and research in this area continues on full-speed. Our ABRCC researchers reflect on 2020 and look ahead to 2021 with renewed hope.